This bill appropriates $35.6 million to Idaho's Department of Health and Welfare for public health services in fiscal year 2027, while simultaneously reducing funding for laboratory services and health care policy initiatives. It also decreases the number of authorized full-time equivalent positions by three and mandates several reports on program outcomes, vaccine utilization, and immigration status for HIV prevention services. Although the bill was signed by the President, the Governor exercised a line-item veto on the section reducing funds for the Health Care Policy Initiatives Program.
This bill requires legislative approval for the Idaho Department of Health and Welfare to adjust Medicaid payment rates for Federally Qualified Health Centers and Rural Health Clinics when their scope of services changes. It establishes a process where clinics must notify the department 60 days before implementing service changes and submit a rate adjustment application after six months of full implementation, requiring a minimum 4.5% cost increase to qualify. The legislation sets specific timelines for department review and allows clinics to appeal final rate decisions, while also repealing certain existing administrative rules effective October 1, 2026.
This bill expands Medicaid eligibility in Idaho to include adults under 65 with incomes at or below 133% of the federal poverty level who currently lack other coverage. It requires the state to submit necessary plan amendments to the federal government within 90 days and ensures eligibility is not delayed while waiting for federal approval. The legislation includes provisions to maintain federal funding levels and requires a review of the program if federal support decreases, while also mandating community engagement requirements by December 2026 before enrollment becomes effective.
This bill appropriates state and federal funds to the Idaho Department of Health and Welfare and the State Independent Living Council for fiscal year 2027, covering programs like Medicaid, child welfare, mental health services, and substance abuse treatment. It establishes specific funding amounts for various divisions including youth safety, early learning, family partnerships, and benefit payments, while also limiting the number of authorized full-time equivalent positions. The legislation includes requirements for program integrity, monthly Medicaid tracking reports, and cost-sharing for certain services, and directs how specific funds must be used for initiatives like smoking cessation, opioid response, and rural physician incentives.
This bill clarifies that Idaho chiropractors with clinical nutrition certification may prescribe specific non-controlled medications, including certain vitamins (A, B complex, C), minerals (calcium, magnesium, zinc), fluids (saline, dextrose), epinephrine, and oxygen for emergencies. It specifies these drugs must be obtained from licensed sources and administered via approved routes, while prohibiting chiropractors from compounding vitamins/minerals themselves. The law directly affects certified chiropractors in Idaho, allowing them to prescribe these items during practice without altering existing non-prescription supplement use. The bill takes effect July 1, 2026, after passing unanimously in the Idaho Senate.
S 1313 creates a voluntary licensure pathway for pharmacists in Idaho to become naturopathic doctors by requiring them to complete a 160-credit-hour naturopathic program and pass a competency exam, while maintaining their existing pharmacy license. The bill amends Idaho Code to include pharmacists in the definition of "licensed naturopathic doctor" and updates committee structures to reflect this new option, including adding a pharmacist to the formulary committee. The law will take effect on July 1, 2026.
Idaho's H 648 requires health benefit plans covering FDA-approved anticancer medications to treat oral and injected drugs equally for cost-sharing (like copays and deductibles) starting January 1, 2027. This directly affects health insurance plans sold in Idaho that cover anticancer medications, ensuring patients pay the same out-of-pocket costs regardless of whether their medication is taken orally or administered via injection. The bill does not prevent insurers from using formularies, prior authorization, or other standard coverage controls. It specifically applies to medications approved by the FDA for cancer treatment, with the law taking effect July 1, 2026, for implementation.
This bill appropriates $35.7 million to Idaho's Department of Health and Welfare for public health services in fiscal year 2027, while reducing the budget for laboratory services by $78,400 and cutting three full-time equivalent positions. The funding covers physical health services, immunization programs, and disease prevention efforts including suicide prevention, HIV surveillance, and hepatitis monitoring. The legislation requires the department to submit annual reports by December 31, 2026, detailing outcomes and return on investment for these programs. The bill also mandates a specific report on vaccine utilization rates and cost savings from the Immunization Assessment Fund.
This bill updates Idaho Medicaid rules to increase transparency and oversight of payments to healthcare providers, particularly those serving people with disabilities. It establishes specific payment rates based on Medicare equivalents for most services, requires annual cost surveys with audits for residential habilitation providers, and mandates that providers spend allocated funds on direct care worker wages or face potential penalties. The legislation also introduces value-based payment options for certain providers, sets reimbursement percentages for different hospital types, and requires the state to reduce general fund spending on hospital payments by specified amounts. Additionally, it declares certain existing administrative rules null and void as of July 1, 2026, and requires all future provider rate changes to receive legislative approval through the budget process.
H 793 revises Idaho's beer excise tax revenue distribution, affecting state funds and the beer industry. It increases the portion of low-alcohol beer tax revenue (≤5% ABV) going to the substance abuse treatment fund from 12% to 20%, while allocating 33% to the Idaho law enforcement fund (with 60% dedicated to the Project Choice program) and the remainder to the general fund. For high-alcohol beer (>5% ABV), it temporarily adjusts funding to hop growers and wine producers (1.5%/3.5% in 2022-2023, rising to 5%/1.5% permanently from 2024), with the rest going to the general fund. The bill removes obsolete language and takes effect July 1, 2026.
